DexCom (DXCM) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2521311074

DexCom, Inc. is a leading medical device company that specializes in creating and selling continuous glucose monitoring (CGM) systems worldwide. These systems are mainly used by individuals with diabetes and healthcare professionals to monitor glucose levels constantly.

The company offers innovative products like Dexcom G6 and Dexcom G7, which are advanced integrated CGM systems tailored for efficient diabetes management. Additionally, DexCom provides solutions such as Dexcom Share for remote monitoring and Dexcom Real-Time API for seamless integration into digital health apps and devices from third-party developers.

One noteworthy product from DexCom is Dexcom ONE, which is engineered to eliminate the need for traditional finger stick blood glucose testing, making diabetes treatment decisions smoother and more accurate. On a significant note, DexCom has a pending FDA review for Dexcom Stelo, a system designed specifically for individuals with type 2 diabetes.

Furthermore, DexCom has strategic collaborations with Verily Life Sciences LLC and Verily Ireland Limited to develop cutting-edge blood-based or interstitial glucose monitoring products. The company primarily markets its products directly to endocrinologists, physicians, and diabetes educators for widespread use and accessibility.

Founded in 1999 and headquartered in San Diego, California, DexCom continues to drive innovation and set new standards in the field of continuous glucose monitoring. For more information, visit their website at https://www.dexcom.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for DexCom (DXCM) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for DexCom (DXCM) - Stock Price & Dividends

DXCM Stock Overview

Market Cap in USD 51,366m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 2005-04-14

DXCM Stock Ratings

Fundamental 7.32
Dividend -
Growth 5y 6.74
Rel. Performance vs Sector 0.34
Analysts 4.61/5
Fair Price Momentum 144.36 USD
Fair Price DCF 36.08 USD

DXCM Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

DXCM Growth Ratios

Growth 12m 22.39%
Growth Correlation 12m 8%
Growth Correlation 3m 13%
CAGR 5y 37.03%
Sharpe Ratio 12m 0.44
Alpha vs SP500 12m -14.30
Beta vs SP500 5y weekly 1.16
ValueRay RSI 84.24
Volatility GJR Garch 1y 39.99%
Price / SMA 50 11.16%
Price / SMA 200 22.08%
Current Volume 2031.8k
Average Volume 20d 3450.2k

External Links for DXCM Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of DXCM stocks?
As of March 29, 2024, the stock is trading at USD 139.48 with a total of 2,031,775 shares traded.
Over the past week, the price has changed by +5.24%, over one month by +20.95%, over three months by +12.73% and over the past year by +20.17%.
What is the forecast for DXCM stock price target?
According to ValueRays Forecast Model, DXCM DexCom will be worth about 161 in March 2025. The stock is currently trading at 139.48. This means that the stock has a potential upside of +15.46%.
Issuer Forecast Upside
Wallstreet Target Price 148.4 6.38%
Analysts Target Price 137 -1.78%
ValueRay Target Price 161 15.5%